KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2016 - 2025)

Johnson & Johnson's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, changed 0.0%, while the annual FY2025 figure was $2.4 billion, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $2.4 billion at Johnson & Johnson, roughly flat from $2.4 billion in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $2.6 billion in Q1 2021 and bottomed at $2.4 billion in Q2 2025.
  • The 5-year median for Shares Outstanding (Weighted Average) is $2.6 billion (2023), against an average of $2.5 billion.
  • The largest annual shift saw Shares Outstanding (Weighted Average) dropped 7.57% in 2024 before it grew 0.0% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.6 billion in 2021, then dropped by 0.14% to $2.6 billion in 2022, then decreased by 3.63% to $2.5 billion in 2023, then fell by 4.98% to $2.4 billion in 2024, then grew by 0.0% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Shares Outstanding (Weighted Average) are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.4 billion (Q2 2025).